Bio

William Hiltz is a Senior Managing Director of the firm’s strategic advisory business and head of its General Advisory Group and its Special Committee practice. Since joining Evercore, Mr. Hiltz has advised General Mills on its acquisition of Pillsbury, the divestiture of its interest in Ice Cream Partners and the divestiture of its interest in SVE to PepsiCo. He has advised CVS on its acquisition of Eckerd, its acquisition of Albertson’s free standing drugstores and its $27 billion merger with Caremark. He has also advised EDS on the sale of UGS PLM and on its $14 billion sale to Hewlett-Packard, Swiss Re on its acquisition of GE’s reinsurance business, Tyco on its split-up into three separately traded companies, Credit Suisse on its sale of Winterthur, Novelis on its sale to Hindalco and Aquila on its sale to Great Plains. He advised GM on its $173 billion restructuring and its $23.1 billion IPO, Energy Futures Holdings on its $48 billion Chapter 11 reorganization and its pending sale of ONCOR for $18.8 billion, CIT on its $54 billion restructuring and the Special Committee of ACS on its $8.3 billion sale to Xerox. He also advised BP in its negotiations with the U.S. Government concerning the creation and structure of the $20 billion trust fund related to the Gulf of Mexico oil spill. He advised Kraft on the spin-off of its $36 billion North American Grocery business. He advised the Special Committee of McMoRan Exploration on its $4 billion sale to Freeport McMoRan, the Special Committee of Dell on its $24 billion LBO and the Disinterested Directors of Chrysler Group LLC on the purchase by Fiat S.p.A of the VEBA’s 41.5% member interests for $3.65 billion and Oxy on its $14 billion spin off of California Resources, Corp. He also advised CVS Health on its $13 billion acquisition of Omnicare and Broadcom on its $37 billion sale to Avago Technologies. He advised FMC Technologies on its $13 billion merger with Technip, the Special Committee of Facebook on its $300 billion recapitalization and the Special Committee of Hilton on the sale of a 25% position to HNA. He advised the Special Committee of Fortress on the sale to Softbank, the Special Committee of Pilgrim’s Pride on its purchase of Moy Park, Whole Foods on its $14 billion sale to Amazon and the Board of Aetna on its $77 billion sale to CVS Health. Prior to joining Evercore, Mr. Hiltz was Head of the Global Energy Group at UBS Warburg and, prior to UBS’ acquisition of Dillon Read & Co. Inc., Head of the Energy Group at Dillon Read since 1995. From 1982-1995, Mr. Hiltz was a Managing Director at Smith Barney where at various times he headed the Energy Group, the High Yield and Merchant Banking Group, the Transportation Group and the General Industrial Group. Mr. Hiltz has 41 years of experience in the investment banking business, beginning in 1976 when he first joined Dillon Read. Mr. Hiltz is a former Director of Davis Petroleum Corp. and Energy Partners, Ltd. He is a former Trustee of the Salisbury School and currently serves as a Trustee of Lenox Hill Hospital in New York where he served as Chairman from 2003-2014. He also serves as a Trustee and member of the Executive Committee of the North Shore LIJ Health System. He serves as a Director of the National Park Foundation. He is a member of The Council on Foreign Relations. He received a B.A. in History and Government from Dartmouth College and an M.B.A. from The Wharton School at the University of Pennsylvania.